---
title: "Olymvax Biopharmaceuticals plans to issue H shares and list on the Hong Kong Stock Exchange"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/258476354.md"
description: "According to the Zhitong Finance APP, Olymvax Biopharmaceuticals announced that the company is planning to issue overseas shares (H shares) and apply for listing on the Hong Kong Stock Exchange (referred to as \"Hong Kong Stock Exchange\") to deepen its international strategic layout, enhance international visibility and influence, further optimize its capital structure, and strengthen its overall competitive strength"
datetime: "2025-09-23T08:14:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/258476354.md)
  - [en](https://longbridge.com/en/news/258476354.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/258476354.md)
---

# Olymvax Biopharmaceuticals plans to issue H shares and list on the Hong Kong Stock Exchange

According to the Zhitong Finance APP, Olymvax Biopharmaceuticals (688319.SH) announced that the company is planning to issue overseas shares (H shares) and apply for listing on the Hong Kong Stock Exchange (referred to as "Hong Kong Stock Exchange") to deepen its international strategic layout, enhance international visibility and influence, further optimize its capital structure, and strengthen its overall competitive strength

### Related Stocks

- [688319.CN](https://longbridge.com/en/quote/688319.CN.md)

## Related News & Research

- [New York Governor Signs Bills To Preserve Mandatory Vaccines](https://longbridge.com/en/news/286947583.md)
- [Phase 3-ready cancer biotech Parabilis Medicines files for a $100 million IPO](https://longbridge.com/en/news/286972125.md)
- [Microbiotica reports positive results for MB097 in advanced melanoma](https://longbridge.com/en/news/286740265.md)
- [09:35 ETOpen Medicine Launches Ahead of ASCO, Introducing "Living Algorithms" for Real-Time Oncology Decision-Making](https://longbridge.com/en/news/286923155.md)
- [Seegene Launches Allplex™ MDRO Assay Under IVDR: Expanding AMR Testing Portfolio in Europe](https://longbridge.com/en/news/287237973.md)